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Two-dimensional gel electrophoresis (IEP) analysis of short-term [32P]orthophosphate-labelled 
intermediate-sized filament proteins (keratins and vimentin) from transformed mitotic amnion cells 
(AMA), have shown that these proteins are modified coordinately and that the half life of the phosphate 
is about 13 min for the keratins and 11 min for vimentin. These results support he notion that the 
preferential modification of intermediate-sized filament proteins during mitosis may play a role in 
modulating filament associations with organelles and other cellular structures. 
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1. INTRODUCTION 
We have previously shown that transformed am- 
nion cells (AMA) contain 4 keratins (IEF 3 1, M, = 
50000; IEF 36, Mr = 48500; IEF 44, M, = 44000 
and IEF 46, Mr = 43 500; HeLa protein catalogue 
number [l-3]) ([4-61, Celis et al., submitted) in 
addition to vimentin. In mitosis these intermediate 
filament proteins are phosphorylated above their 
interphase level and we have suggested that the 
modifications may be instrumental in assuring the 
process of cell division ([7-lo], Celis .et al., 
submitted). 
Here, we present evidence indicating that in 
mitotic AMA cells all of the intermediate-sized 
filament proteins are coordinately modified and 
that the half-life of the phosphate is about 13 min 
for the keratins and 11 min for vimentin. These 
results are taken to support the notion that the 
preferential phosphorylation of intermediate-sized 
Abbreviation: IEF, isoelectric focussing 
filaments during mitosis may play a role in 
modulating filament associations with organelles 
and other cell structures ([g-20], Celis et al., 
submitted). 
2. MATERIALS AND METHODS 
2.1. Isolation of mitotic ceils 
Mitotic cells were obtained by mechanical 
detachment as described for HeLa cells [21]. Three 
250-ml flasks containing about 2 x lo6 cells per 
flask were used. The distribution of phases in a 
mitotic population gave 16% prophase, 65% 
metaphase (early and late metaphase), 13% 
telophase and 8% interphase. 
2.2. Labelling of mitotic ceils with f’s]- 
methionine 
Mitotic cells harvested at 20°C were labelled at 
37’C with [‘5S]methionine for 10 min as in 
121-231. At the end of the labelling period the cells 
were centrifuged and resuspended immediately in 
lysis buffer [24]. 
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2.3. Labelling of ceils with [32P]orthophosphate 
Mitotic cells harvested at 20°C were labelled at 
37°C for various periods of time in 2 ml of 
phosphate-free medium containing 1 mCi of 
[32P]orthophosphate. After labelling or chasing, 
the cells were centrifuged and resuspended im- 
mediately in lysis buffer. 
The procedures for two-dimensional gel elec- 
trophoresis (IEF) [7,24], silver staining [10,25] and 
immunoprecipitation [5,9] have been previously 
described. 
3. RESULTS AND DISCUSSION 
Fig.1 shows an IEF gel of [35S]methionine pro- 
teins from mitotic AMA cells obtained by 
mechanical detachment and labelled for 10 min at 
37°C. The position of the 4 keratins present in 
these cells (IEF 31, Mr = 50000; IEF 36, 
MI = 48500; IEF 44, A& = 44000 and IEF 46, 
iW, = 43500; HeLa proteins catalogue number 
[l-3 1 J) ([4-61, Celis et al., submitted), vimentin 
(v, IEF 26 in the HeLa protein catalogue), (Y- and 
&tubulin and total actin are indicated. Some of the 
phosphorylated variants of the keratins and of 
IEFB 
Fig. 1. Two-dimensional gel electrophoresis (IEF) of 
[35Slmethionine-labelled proteins from mitotic AMA 
cells labelled for 10 min. IEF 31, 36, 44 and 46 
correspond to keratins, v = vimentin; a-t = cr-tubulin; 
,& = @-tubulin. Some modified variants of the keratins 
and of vimentin are also indicated. 
vimentin are also indicated with their correspon- 
ding number in the HeLa protein catalogue. 
Similar gel electrophoretic analysis (IEF) of 
mitotic AMA proteins stained with silver nitrate 
are shown in fig.2 (only the relevant fraction of the 
gel is shown). Clearly, the modifications of 
keratins IEF 36 and 44 are quite substantial as 
compared to those of keratins IEF 31, 46 and 
vimentin. 
Labelling of mitotic AMA cells with [32P]or- 
thophosphate (10 min) followed by analysis of the 
proteins by two-dimensional gel electrophoresis 
(IEF) revealed numerous phosphoiylated variants 
of the 4 keratins and of vimentin (fig.3a; only the 
relevant fraction of the gel is shown; see also table 
1). Since in all cases the intensity of the 32P labelled 
spots is higher than that observed with [35S]- 
methionine (fig.1) or by silver staining (fig.2), it 
seems reasonable to assume that these variants 
arise from increased phosphorylations. The spots 
which are preferentially observed during mitosis 
are underlined in table 1 (Celis et al., submitted). 
Nearly identical patterns to that presented in fig.3a 
have been obtained by labelling as short as 2 min. 
These results strongly suggest hat the keratins as 
well as vimentin are coordinately modified. The 
authenticity of the modified keratins has been 
verified by immunoprecipitating [32P]orthophos- 
phate-labelled proteins from asynchronous AMA 
cells (fig.4a) with a broad specificity keratin anti- 
body. The modified variants move to the acidic site 
of the keratins as judged from similar immunopre- 
IEF- 
Fig.2. Two-dimensional gel electrophoresis (IEF) of 
proteins from mitotic AMA cells stained with silver 
nitrate. Only the relevant fraction of the gel is shown. 
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IEF ---w 
IEF- 
Fig.3. Immunoprecipitation f keratins using a broad 
specificity keratin antibody. (a) Immunoprecipitation of 
3zP-labeIled proteins from asynchronous AMA cells; (b) 
Immunoprecipitation f [3sS]methionine-labelled asyn- 
chronous AMA cells. Phospho~imentin (a)and actin (b) 
are usual contaminants in immunoprecipitates. 
cipitation studies of [35S]methionine-labelled 
AMA proteins (fig.4b). 
To determine the half-life of the phosphate in 
the modified proteins we labelled mitotic AMA 
cells for 10 min with [32P]orthophosphate (fig.3a) 
and then chased the radioactivity for various 
periods of time within the length of the AMA 
mitotic cycle. The relevant fraction of gels (IEF) 
from 32P-labelled proteins chased for 5 min 
(fig.4b), 15 min (fig.4c) and 25 min (fig.4d) are 
IEF ----w 
Fig.4. Phosphate turnover of phosphorylatcd keratins and vimentin. (a) Control cells labelled for 10 min with 
[3zP]o~hophospbate; (b-d) As (a) but chased for 5 min (b), 15 min (c) and 25 min (d), respectively. The same total 
number of counts was applied to each gel. The short arrow indicates a spot whose radioactivity remains constant 
throughout the chase period. 
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Table 1 
Phosphorylated products of keratins and vimentin 
Intermediate-sized 
filament protein* 
Phosphorylated spa@ 
Keratins 
IEF 31 
IEF 36 
IEF 44 
IEF 46 
31a, 31b, 3l.c 
37, m, 35b. 33p 
4484% &!!I1 
46ac, 46b’ 
Vimentin 
Vimentin 26% 26el, 26e2 
a Numbered according to the HeLa protein catalogue 
H-31 
b The underlined numbers correspond to variants 
observed predominantly in mitosis (Celis et al., 
submitted) 
’ These numbers are new additions to the HeLa protein 
catalogue [l-3] 
Fig.5. Rate of phosphate turnover of phosphorylated 
keratins and vimentin. Regions containing the labelled 
polypeptides (see fig.4) were cut from the gels and 
counted in scintillation fluid. The counts were corrected 
to the same total counts applied to the gel; and for 
radioactive decay. (ti) keratin IEF 31; (M) 
keratin IEF 36; (M) keratin IEF 44; (T--T) keratin 
IEF 46; (w) vimentin (IEF 26). 
shown in fig.4. To determine the half-life of the 
phosphate associated with the variants, the spots 
were cut out (pooled sample of variants in each 
case) and their radioactivity determined. 
Fig.5 shows semi-log plots of these data. An 
estimated half-life for the phosphate of about 13 f 
2 min @ < 0.05) for keratins and 11 1- 3 min @ < 
0.05) for vimentin was observed. These values are 
compatible with a regulatory role for phosphoryla- 
tion during mitosis. It may be possible that the 
calculated half-life of the phosphate is affected by 
degradation [7,26-281 but this has not been 
analysed further. Authors in [29] have shown that 
the half life of the phosphate associated with 
vimentin in asynchronous CHO cells is about 
60 min, while the half-life of the vimentin protein 
is considerably longer. Likewise, authors in [30] 
reported similar results in control and colcemide- 
treated CHO cells. At prsent we have not deter- 
mine the half-life of the phosphorylated forms of 
the keratins and of vimentin during interphase 
(Celis et al., submitted), as this will require a 
careful analysis of each phase of the cell cycle. 
It should be stressed that intermediate-sized fila- 
ment proteins exhibit significantly different levels 
of modification in mitosis. Determination of the 
fate of the modified proteins will be a further step 
towards understanding the role of phosphorylation 
in this phase of the cell cycle. 
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